MedicaidCoverageHigh impact
Silver State Scripts Board Made Changes to the Preferred Drug List Effective February 1, 2026
Nevada Medicaid·NV · Cardiology, Endocrinology, Psychiatry +4 more·Pharmacy
Effective date
Feb 1, 2026
We identified it
Jun 21, 2026
Summary
Nevada Medicaid made extensive changes to their Preferred Drug List effective February 1, 2026, moving many brand-name drugs to non-preferred status while promoting generic alternatives to preferred status. Multiple drug classes are affected including heart failure medications, anticoagulants, ADHD medications, diabetes drugs, and others, with significant prior authorization and coverage changes.
Action Required
By February 1, 2026: Update billing and prior authorization systems to reflect Nevada Medicaid PDL changes. Notify providers that brand drugs like Entresto, Adderall XR, Januvia, and Janumet now require prior authorization or are non-preferred. Update formulary information in EMR systems. Train staff on new preferred alternatives including generic sacubitril/valsartan, lisdexamfetamine, and sitagliptin. Failure to obtain required prior authorizations will result in claim denials.